Circulating angiogenic factors associated with response and survival in patients with acute graft-versus-host disease: results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802
about
The Blood and Marrow Transplant Clinical Trials Network: An Effective Infrastructure for Addressing Important Issues in Hematopoietic Cell TransplantationAngiogenic Factors Correlate with T Cell Immune Reconstitution and Clinical Outcomes after Double-Unit Umbilical Cord Blood Transplantation in Adults.Plasma biomarkers of acute GVHD and nonrelapse mortality: predictive value of measurements before GVHD onset and treatment.How I treat acute graft-versus-host disease of the gastrointestinal tract and the liver.Steroids Versus Steroids Plus Additional Agent in Frontline Treatment of Acute Graft-versus-Host Disease: A Systematic Review and Meta-Analysis of Randomized Trials.Pathophysiology of GvHD and Other HSCT-Related Major Complications.Plasma-derived proteomic biomarkers in human leukocyte antigen-haploidentical or human leukocyte antigen-matched bone marrow transplantation using post-transplantation cyclophosphamide.Angiogenic factors and inflammation in steroid-refractory acute graft-vs-host disease.A risk-adapted approach to acute GVHD treatment: are we there yet?Predictive Value of Clinical Findings and Plasma Biomarkers after Fourteen Days of Prednisone Treatment for Acute Graft-versus-host Disease.Placental growth factor: What hematologists need to know.Late acute graft-versus-host disease: a prospective analysis of clinical outcomes and circulating angiogenic factors.Circulating endothelial cell count: a reliable marker of endothelial damage in patients undergoing hematopoietic stem cell transplantation.PlGF enhances TLR-dependent inflammatory responses in human mononuclear phagocytes.Angiogenesis Status in Patients with Acute Myeloid Leukemia: From Diagnosis to Post-hematopoietic Stem Cell TransplantationLow day +100 serum epidermal growth factor levels are associated with acute GvHD after allogeneic hematopoietic cell transplantation.Serum and Extracellular Vesicle MicroRNAs miR-423, miR-199, and miR-93* As Biomarkers for Acute Graft-versus-Host Disease.Donor and recipient plasma follistatin levels are associated with acute GvHD in Blood and Marrow Transplant Clinical Trials Network 0402.Profile of Inflammation-Associated Proteins in Early Post-Transplant Samples of Patients After Allogeneic Hematopoietic Stem Cell Transplantation: a Preliminary Study.Acute graft-versus-host disease of the gut: considerations for the gastroenterologist.A proposed biology- and biomarker-based algorithm for management of acute GvHD.Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802
P2860
Q26740251-8BC0E989-20C8-4A54-A5FC-DC76AEB65758Q33847973-F9D9B52A-FA05-4C99-BB18-F09B79DAA094Q35820356-4ADDB6ED-3E49-404C-B92C-27079C854211Q36727862-84C0E8C7-08DE-4D43-8DC9-D8FB32F84CFCQ37302887-6E568314-65EC-4A1F-82D2-0806054D350FQ37710572-D97CB2B9-D8B0-45C6-B278-BA51D5E6A192Q38381708-CD079184-2CD9-4A53-B0EB-B54BFE52D42BQ38539063-6F5F547F-DB44-4401-9455-0A1C4CFA383BQ38628944-11088658-8079-4CCA-9D49-464EB273B27BQ38800455-0460AE75-D684-4090-984D-D271FE579F38Q38823169-F42041C2-DC4B-4135-9789-865B2410C511Q39393617-D8E79950-1101-42E4-8281-1DBF49E6075DQ40053904-EEEB2379-0017-4516-A57C-3DE9DE2581E3Q40151689-2D6D5DF8-E040-4ADE-9C2F-66C8C2D3EA2BQ41313323-5ECE8F1A-15D3-443B-B0D8-CF7624A147F8Q41598667-FBD743E5-6E6F-42AF-A497-13CF5E60CF99Q47158588-B5FB5590-5246-4E9E-9AA1-71250BE3EEF3Q47743495-21DF7525-EC2B-48BA-8C71-216899408B5CQ48355836-091973F9-D0E9-4D24-95AC-F9ABED153017Q49806345-6A2C6D8E-7373-4981-A3E4-07FDF1853803Q50545248-2BB5DAA6-7744-4673-9ECE-F2BDF6EB5393Q58797078-B9AB50BF-B98B-4AF8-9B3C-98FAC9C9D05D
P2860
Circulating angiogenic factors associated with response and survival in patients with acute graft-versus-host disease: results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Circulating angiogenic factors ...... l Trials Network 0302 and 0802
@ast
Circulating angiogenic factors ...... l Trials Network 0302 and 0802
@en
type
label
Circulating angiogenic factors ...... l Trials Network 0302 and 0802
@ast
Circulating angiogenic factors ...... l Trials Network 0302 and 0802
@en
prefLabel
Circulating angiogenic factors ...... l Trials Network 0302 and 0802
@ast
Circulating angiogenic factors ...... l Trials Network 0302 and 0802
@en
P2093
P2860
P1476
Circulating angiogenic factors ...... l Trials Network 0302 and 0802
@en
P2093
Arne Slungaard
Daniel J Weisdorf
Gabrielle Meyers
Gregory M Vercellotti
Kirk R Schultz
Laura F Newell
Margaret L MacMillan
Michael R Verneris
Sarah A Cooley
P2860
P304
P356
10.1016/J.BBMT.2015.02.018
P577
2015-03-07T00:00:00Z